These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8834236

  • 1. Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan.
    Kobayashi S, Iwata T, Saito M, Iwasaki R, Matsumoto H, Naritaka S, Kono Y, Hayashi Y.
    Hum Genet; 1996 Apr; 97(4):424-30. PubMed ID: 8834236
    [Abstract] [Full Text] [Related]

  • 2. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
    Hagemann TL, Rosen FS, Kwan SP.
    Hum Mutat; 1995 Apr; 5(4):296-302. PubMed ID: 7627183
    [Abstract] [Full Text] [Related]

  • 3. Mutation analysis of the gene encoding Bruton's tyrosine kinase in a family with a sporadic case of X-linked agammaglobulinemia reveals three female carriers.
    Hagemann TL, Assa'ad AH, Kwan SP.
    Am J Med Genet; 1995 Nov 06; 59(2):188-92. PubMed ID: 8588584
    [Abstract] [Full Text] [Related]

  • 4. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
    Vorechovský I, Luo L, Hertz JM, Frøland SS, Klemola T, Fiorini M, Quinti I, Paganelli R, Ozsahin H, Hammarström L, Webster AD, Smith CI.
    Hum Mutat; 1997 Nov 06; 9(5):418-25. PubMed ID: 9143921
    [Abstract] [Full Text] [Related]

  • 5. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V, Seidenspinner S, Kreth HW.
    Am J Med Genet; 1996 May 03; 63(1):318-22. PubMed ID: 8723128
    [Abstract] [Full Text] [Related]

  • 6. Molecular analysis of Bruton's tyrosine kinase gene in Spain.
    Rodríguez MC, Granados EL, Cerdán AF, Casariego GF.
    Hum Mutat; 2001 May 03; 18(1):84. PubMed ID: 11438999
    [Abstract] [Full Text] [Related]

  • 7. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM, Wang Y, Kanegane H, Futatani T, Pinto J, Vilela MM, Miyawaki T.
    Hum Mutat; 2002 Sep 03; 20(3):235-6. PubMed ID: 12204007
    [Abstract] [Full Text] [Related]

  • 8. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK, Curtis SK, Vogler LB, Vihinen M.
    Mol Med; 1997 Jul 03; 3(7):477-85. PubMed ID: 9260159
    [Abstract] [Full Text] [Related]

  • 9. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, Vihinen M, Hubbard SR, Belohradsky BH, Smith CI, Meindl A.
    Pediatrics; 1998 Feb 03; 101(2):276-84. PubMed ID: 9445504
    [Abstract] [Full Text] [Related]

  • 10. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
    Fiorini M, Franceschini R, Soresina A, Schumacher RF, Ugazio AG, Rossi P, Plebani A, Notarangelo LD.
    Hum Mutat; 2004 Mar 03; 23(3):286. PubMed ID: 14974089
    [Abstract] [Full Text] [Related]

  • 11. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
    Kristufek D, Aspalter RM, Eibl MM, Wolf HM.
    Mol Immunol; 2007 Mar 03; 44(7):1639-43. PubMed ID: 17045652
    [Abstract] [Full Text] [Related]

  • 12. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T.
    J Allergy Clin Immunol; 2001 Dec 03; 108(6):1012-20. PubMed ID: 11742281
    [Abstract] [Full Text] [Related]

  • 13. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P, Ritis K, Moschese V, Angelini F, Arvanitidis K, Speletas M, Sideras P, Plebani A, Rossi P.
    Hum Mutat; 2000 Jan 03; 15(1):117. PubMed ID: 10612838
    [Abstract] [Full Text] [Related]

  • 14. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB, Lester T, Levinsky RJ, Kinnon C.
    Clin Exp Immunol; 1998 Feb 03; 111(2):334-8. PubMed ID: 9486400
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
    Mattsson PT, Vihinen M, Smith CI.
    Bioessays; 1996 Oct 03; 18(10):825-34. PubMed ID: 8885720
    [Abstract] [Full Text] [Related]

  • 17. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia.
    Vihinen M, Kwan SP, Lester T, Ochs HD, Resnick I, Väliaho J, Conley ME, Smith CI.
    Hum Mutat; 1999 Oct 03; 13(4):280-5. PubMed ID: 10220140
    [Abstract] [Full Text] [Related]

  • 18. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
    Wang Y, Kanegane H, Sanal O, Ersoy F, Tezcan I, Futatani T, Tsukada S, Miyawaki T.
    Hum Mutat; 2001 Oct 03; 18(4):356. PubMed ID: 11668622
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.